Evidence map›Paper›PMID 24602368›Full record

ArticleBMC dermatology2014

Distribution of Malassezia species on the skin of patients with atopic dermatitis, psoriasis, and healthy volunteers assessed by conventional and molecular identification methods.

Tomasz Jagielski, Elżbieta Rup, Aleksandra Ziółkowska, Katarzyna Roeske, Anna B Macura, Jacek Bielecki

Abstract read
In one paragraph

Article in BMC dermatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Interplay between Humoral and CLAInternational journal of molecular sciences · 2021
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Extracellular vesicles produced byExtracellular vesicles and circulating nucleic acids · 2026
    Review
  7. Article
  8. Article
  9. Fungal Biofilm: An Overview of the Latest Nano-Strategies.Antibiotics (Basel, Switzerland) · 2025
    Review
  10. Article
  11. Article
  12. Fungal Head and Neck Dermatitis: Current Understanding and Management.Clinical reviews in allergy & immunology · 2024
    Review
  13. Article
  14. Review
  15. Malassezia spp. and Candida spp. from patients with psoriasis exhibit reduced susceptibility to antifungals.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023
    Article
  16. Review
  17. Article
  18. The Role of the Cutaneous Mycobiome in Atopic Dermatitis.Journal of fungi (Basel, Switzerland) · 2022
    Review
  19. In Vitro Assessment of Azole and Amphotericin B Susceptibilities ofJournal of fungi (Basel, Switzerland) · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tomasz JagielskiDepartment of Applied Microbiology, Institute of Microbiology, Faculty of Biology, University of Warsaw, I, Miecznikowa 1, 02-096 Warsaw, Poland. t.jagielski@biol.uw.edu.pl.
Elżbieta Rup
Aleksandra Ziółkowska
Katarzyna Roeske
Anna B Macura
Jacek Bielecki

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Malassezia yeasts which belong to the physiological microflora of human skin have also been implicated in several dermatological disorders, including pityriasis versicolor (PV), atopic dermatitis (AD), and psoriasis (PS). The Malassezia genus has repeatedly been revised and it now accommodates 14 species, all but one being lipid-dependent species. The traditional, phenotype-based identification schemes of Malassezia species are fraught with interpretative ambiguities and inconsistencies, and are thus increasingly being supplemented or replaced by DNA typing methods. The aim of this study was to explore the species composition of Malassezia microflora on the skin of healthy volunteers and patients with AD and PS.

methodsSpecies characterization was performed by conventional, culture-based methods and subsequently molecular techniques: PCR-RFLP and sequencing of the internal transcribed spacer (ITS) 1/2 regions and the D1/D2 domains of the 26S rRNA gene. The Chi-square test and Fisher's exact test were used for statistical analysis.

resultsMalassezia sympodialis was the predominant species, having been cultured from 29 (82.9%) skin samples collected from 17 out of 18 subjects under the study. Whereas AD patients yielded exclusively M. sympodialis isolates, M. furfur isolates were observed only in PS patients. The isolation of M. sympodialis was statistically more frequent among AD patients and healthy volunteers than among PS patients (P < 0.03). Whether this mirrors any predilection of particular Malassezia species for certain clinical conditions needs to be further evaluated. The overall concordance between phenotypic and molecular methods was quite high (65%), with the discordant results being rather due to the presence of multiple species in a single culture (co-colonization) than true misidentification. All Malassezia isolates were susceptible to cyclopiroxolamine and azole drugs, with M. furfur isolates being somewhat more drug tolerant than other Malassezia species.

conclusionsThis study provides an important insight into the species composition of Malassezia microbiota in human skin. The predominance of M. sympodialis in both normal and pathologic skin, contrasts with other European countries, reporting M. globosa and M. restricta as the most frequently isolated Malassezia species.

Indexed as

AdultAgedAnti-Bacterial AgentsDermatitis, AtopicDermatomycosesDNA, FungalFemaleHumansMalasseziaMaleMicrobial Sensitivity TestsMiddle AgedMolecular Diagnostic TechniquesMolecular Sequence DataMycologyPolymerase Chain ReactionAnti-Bacterial AgentsDNA, Fungal

Identifiers

PMID24602368
PMCPMC3975586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.